Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
71.29M | 83.29M | 69.83M | 62.87M | 78.49M | 110.91M | Gross Profit |
34.05M | 83.29M | 28.94M | 21.73M | 35.12M | 56.35M | EBIT |
14.28M | 25.34M | -1.07M | -7.28M | 9.78M | 32.73M | EBITDA |
14.11M | 25.34M | -1.07M | 10.40M | 23.21M | 43.91M | Net Income Common Stockholders |
20.52M | 27.13M | -29.23M | 1.54M | 7.93M | 24.05M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
32.59M | 31.89M | 18.55M | 12.33M | 12.15M | 9.74M | Total Assets |
118.16M | 114.19M | 90.84M | 132.20M | 136.63M | 141.23M | Total Debt |
2.20M | 1.72M | 3.05M | 4.87M | 13.08M | 11.51M | Net Debt |
-28.89M | -30.18M | -15.50M | -7.46M | 931.00K | 1.77M | Total Liabilities |
26.31M | 25.82M | 30.97M | 45.08M | 53.29M | 58.70M | Stockholders Equity |
91.85M | 88.36M | 59.87M | 87.11M | 83.34M | 82.52M |
Cash Flow | Free Cash Flow | ||||
9.87M | 15.22M | 8.20M | 6.97M | 9.67M | 9.55M | Operating Cash Flow |
10.11M | 15.27M | 15.99M | 18.76M | 21.91M | 24.76M | Investing Cash Flow |
2.79M | 2.27M | -8.90M | -11.80M | -12.24M | -15.20M | Financing Cash Flow |
-5.26M | -1.69M | -1.63M | -6.96M | -6.44M | -9.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $79.81M | 3.84 | 25.65% | 4.44% | -1.32% | ― | |
62 Neutral | $11.90B | 10.64 | -7.50% | 2.90% | 7.41% | -8.19% | |
50 Neutral | AU$32.08M | ― | -52.29% | ― | 4.10% | -115.05% | |
AU$17.67M | ― | -1.14% | ― | ― | ― | ||
52 Neutral | AU$23.75M | ― | -24.21% | ― | -11.35% | -49.13% | |
43 Neutral | AU$39.88M | ― | -1801.55% | ― | 27.94% | 28.75% | |
35 Underperform | AU$35.51M | ― | -243.28% | ― | -32.45% | 33.72% |
Integrated Research Limited announced the cessation of certain securities, specifically 1,012,530 performance rights and 655,809 options, due to the conditions for these securities not being met or becoming incapable of being satisfied. This cessation may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational and financial strategies.
Integrated Research Limited has secured a significant renewal contract with JP Morgan Chase, valued at USD $6.23 million (AUD $9.80 million), for a 5-year term. This contract involves the use of IR’s Transact and Infrastructure product, which is crucial for JP Morgan Chase’s payments technology. The renewal underscores the longstanding relationship and the evolving value of IR’s technology for large enterprise clients, reinforcing its position in the industry.